Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers

Irmejs, ArvidsPurkalne, GuntaBitina, MariannaGardovskis, AndrisGardovskis, Janis2021-10-312021-10-312007-09-15Irmejs, A, Purkalne, G, Bitina, M, Gardovskis, A & Gardovskis, J 2007, 'Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers', Hereditary cancer in clinical practice, vol. 5, no. 3, 119, pp. 125-126. < https://hccpjournal.biomedcentral.com/track/pdf/10.1186/1897-4287-5-3-119.pdf >1731-2302https://dspace.rsu.lv/jspui/handle/123456789/67732233979enginfo:eu-repo/semantics/openAccess3.2 Clinical medicine3.1 Basic medicine1.1. Scientific article indexed in Web of Science and/or Scopus databaseOncologyGenetics(clinical)SDG 3 - Good Health and Well-beingDiscussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/commenthttp://www.scopus.com/inward/record.url?scp=35348883267&partnerID=8YFLogxKhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736985/https://hccpjournal.biomedcentral.com/track/pdf/10.1186/1897-4287-5-3-119.pdf